Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: A Phase 1 Multidose Study to Evaluate the Safety and Tolerability of XmAb13676 in Patients With CD20-Expressing Hematologic Malignancies
Brief Summary: This study will determine a dose and schedule for XmAb13676 in the treatment of CD20 expressing hematologic malignancies.